Partnerships are only as good as their ability to turn the NXS products into large revenue for NXS. So far we are stumbling but time will tell and this quarter will give us some good insight into the successes / challenges ahead in 2020. Looking forward to this quarters report.
Charts NXS, page-511
-
-
- There are more pages in this discussion • 424 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NXS (ASX) to my watchlist
(20min delay)
|
|||||
Last
15.0¢ |
Change
0.005(3.45%) |
Mkt cap ! $43.82M |
Open | High | Low | Value | Volume |
15.5¢ | 16.0¢ | 14.0¢ | $58.48K | 396.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 5028 | 14.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
15.0¢ | 37881 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 5028 | 0.145 |
1 | 715 | 0.140 |
1 | 6700 | 0.135 |
4 | 38210 | 0.130 |
1 | 2000 | 0.125 |
Price($) | Vol. | No. |
---|---|---|
0.150 | 37881 | 1 |
0.155 | 3000 | 1 |
0.160 | 28820 | 3 |
0.165 | 1500 | 1 |
0.170 | 12689 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
NXS (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online